These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14656874)

  • 41. RU486-inducible retrovirus-mediated caspase-3 overexpression is cytotoxic to bcl-xL-expressing myeloma cells in vitro and in vivo.
    Pollett JB; Zhu YX; Gandhi S; Bali M; Masih-Khan E; Li Z; Wen XY; Stewart AK
    Mol Ther; 2003 Aug; 8(2):230-7. PubMed ID: 12907145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.
    van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM
    Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
    Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M
    Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bcl-XL expression in stem cells facilitates engraftment and reduces the need for host conditioning during bone marrow transplantation.
    Mata M; Chiffoleau E; Adler SH; Gray T; Hancock W; Turka LA
    Am J Transplant; 2004 Jan; 4(1):58-64. PubMed ID: 14678035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL.
    Vikström IB; Slomp A; Carrington EM; Moesbergen LM; Chang C; Kelly GL; Glaser SP; Jansen JH; Leusen JH; Strasser A; Huang DC; Lew AM; Peperzak V; Tarlinton DM
    Cell Death Dis; 2016 Aug; 7(8):e2345. PubMed ID: 27560714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.
    Grillot DA; Merino R; Núñez G
    J Exp Med; 1995 Dec; 182(6):1973-83. PubMed ID: 7500043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.
    McDonnell TJ; Nunez G; Platt FM; Hockenberry D; London L; McKearn JP; Korsmeyer SJ
    Mol Cell Biol; 1990 May; 10(5):1901-7. PubMed ID: 2183011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.
    Hentunen TA; Reddy SV; Boyce BF; Devlin R; Park HR; Chung H; Selander KS; Dallas M; Kurihara N; Galson DL; Goldring SR; Koop BA; Windle JJ; Roodman GD
    J Clin Invest; 1998 Jul; 102(1):88-97. PubMed ID: 9649561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells.
    Blanco-Colio LM; Justo P; Daehn I; Lorz C; Ortiz A; Egido J
    Kidney Int; 2003 Jul; 64(1):181-91. PubMed ID: 12787408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.
    Pena JC; Rudin CM; Thompson CB
    Cancer Res; 1998 May; 58(10):2111-6. PubMed ID: 9605754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY; Stein CA
    Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
    Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
    Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
    Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
    Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways.
    Mori N; Fujii M; Cheng G; Ikeda S; Yamasaki Y; Yamada Y; Tomonaga M; Yamamoto N
    Virus Genes; 2001 Jun; 22(3):279-87. PubMed ID: 11450946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential regulation of the antiapoptotic action of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma extra long (Bcl-xL) by c-Jun N-terminal protein kinase (JNK) 1-involved pathway in neuroglioma cells.
    Jeong HS; Choi HY; Choi TW; Kim BW; Kim JH; Lee ER; Cho SG
    Biol Pharm Bull; 2008 Sep; 31(9):1686-90. PubMed ID: 18758060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.